Status:
COMPLETED
Adult Outcomes of Children With CAPS
Lead Sponsor:
University Hospital, Lille
Conditions:
Cryopyrin Associated Periodic Syndrome
Eligibility:
All Genders
16+ years
Brief Summary
The patients included in this study were followed up in the Internal Medicine and Paediatrics Departments of the Lille CHU, the Paediatric Rheumatology and Immunology Department of the Necker Enfant M...
Eligibility Criteria
Inclusion
- Diagnosis of FCAS, Muckle-Wells or NOMID/CINCA;
- age \< 16 years at the apparition of the first symptoms of the disease;
- age ≥ 16 years old at inclusion
- follow-up in a CEREMAIA reference or competence center.
Exclusion
- Age \< 16 years at inclusion;
- non-consenting patient
Key Trial Info
Start Date :
September 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 25 2022
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04856540
Start Date
September 16 2021
End Date
February 25 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Claude Huriez Chu Lille
Lille, France, 59037